Omaveloxolone for the Treatment of Friedreich Ataxia: Efficacy, Safety, and Future Perspectives

Affiliations

• ¹ O'Brien Institute Department, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
• ² Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
• ³ Department of Paediatrics, Melbourne University, Parkville, Victoria, Australia.
• ⁴ School of Medical, Indigenous and Health Sciences, Molecular Horizons, University of Wollongong, Wollongong, New South Wales, Australia.
• ⁵ Victorian Clinical Genetics Services, Parkville, Victoria, Australia.
• ⁶ Department of Medicine and Surgery, University of Melbourne, Parkville, Victoria, Australia.
• ⁷ Drug Discovery Biology, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Clayton, Victoria, Australia.
• ⁸ National Heart Research Institute, National Heart Center, Singapore.